Stock Alert: Check-Cap Jumps To New 52-week High

Shares of Check-Cap Ltd. (CHEK), an Israel-based clinical stage medical diagnostics company, are surging more than 66 percent or $0.97 in Tuesday's morning trade at $2.42, after hitting a new 52-week high of $2.93.

Check-Cap has extended gains in recent sessions after the company disclosed in a regulatory filing on December 30, 2020 that Nasdaq Stock Market LLC has granted it a 180-day extension to regain compliance.

Check-Cap now has time until June 28, 2021, for its ordinary shares to maintain a minimum bid price of $1.00 per share for continued listing on the Nasdaq Capital Market.

Check-Cap has traded in a range of $0.24 to $2.93 in the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Pharma Stocks by Subscribing to RTT Biotech Investor.
Editors Pick
Sandoz, Inc., an unit of Novartis AG, is recalling one lot of deep vein thrombosis (DVT) medication Enoxaparin Sodium in the form of injection for the potential exposure to high temperatures that may have impacted product effectiveness, the U.S. Food and Drug Administration or FDA said in a statement. Livia Global, Inc., a health and wellness company, is recalling two lots of its Liviaone liquid probiotics citing the possibility of contamination by Pseudomonas aeruginosa, the U.S. Food and Drug Administration said. Pseudomonas aeruginosa is a microorganism found in the environment that, if ingested, can cause life-threatening infection in immunocompromised individuals. United Airlines operated Thursday the first ever passenger flight using 100% Sustainable Aviation Fuel or SAF as part of its efforts to combat climate change. The airline flew the green flight from Chicago's O'Hare International Airport or ORD to Washington, D.C.'s Reagan National Airport or DCA with more than 100 passengers.
Follow RTT